{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:54:33Z","timestamp":1793652873889,"version":"4.5.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Aging Clin Exp Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>This study aimed to investigate the complex associations of frailty and high-sensitivity C-reactive protein (hsCRP) with cardiovascular disease (CVD) through a nationwide prospective cohort, while also assessing the mediating associations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>According to critical criteria, a total of 5239 participants from the China Health and Retirement Longitudinal Study (CHARLS) in 2011 were ultimately enrolled in this study. Frailty was evaluated by the frailty index with 40 items, and CVD was defined as the presence of physician-diagnosed heart disease and\/or stroke. A restricted cubic spline model, receiver operating characteristic curves, adjusted Cox proportional hazards regression, interaction analyses and mediation analyses were performed for association exploration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>During a maximum follow-up of 7.0\u00a0years, 1204 (23.67%) people developed CVD. Both elevated hsCRP and frailty were significantly associated with CVD incidence. Compared with participants with a healthy status and low hsCRP (&lt;\u20091.015\u00a0mg\/L), those with a frailty status and elevated hsCRP had the highest risk of CVD (adjusted HR, 2.97; 95% CI 2.29\u20133.84), heart disease (adjusted HR, 2.93; 95% CI 2.16\u20133.96), and stroke (adjusted HR, 4.26; 95% CI 2.81\u20136.44), which were still robust in the subgroup analysis. Moreover, frailty significantly mediated 19.60% of the associations between hsCRP and CVD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Combined assessment of frailty and hsCRP levels helps to better stratify the individual risk of CVD. Frailty could partly mediate the associations between hsCRP and CVD incidence.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s40520-025-02928-6","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T13:50:56Z","timestamp":1740750656000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Frailty, high-sensitivity C-reactive protein and cardiovascular disease: a nationwide prospective cohort study"],"prefix":"10.1007","volume":"37","author":[{"given":"Lei","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyang","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qihao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,28]]},"reference":[{"key":"2928_CR1","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","volume":"76","author":"GA Roth","year":"2020","unstructured":"Roth GA, Mensah GA, Johnson CO et al (2020) Global burden of cardiovascular diseases and risk factors, 1990\u20132019: update from the GBD 2019 study. J Am Coll Cardiol 76:2982\u20133021","journal-title":"J Am Coll Cardiol"},{"key":"2928_CR2","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1016\/j.jacc.2022.11.005","volume":"80","author":"M Vaduganathan","year":"2022","unstructured":"Vaduganathan M, Mensah GA, Turco JV et al (2022) The global burden of cardiovascular diseases and risk: a compass for future health. J Am Coll Cardiol 80:2361\u20132371","journal-title":"J Am Coll Cardiol"},{"key":"2928_CR3","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/S0140-6736(12)62167-9","volume":"381","author":"A Clegg","year":"2013","unstructured":"Clegg A, Young J, Iliffe S et al (2013) Frailty in elderly people. Lancet 381:752\u2013762","journal-title":"Lancet"},{"key":"2928_CR4","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1093\/eurheartj\/ehad885","volume":"45","author":"D He","year":"2024","unstructured":"He D, Wang Z, Li J et al (2024) Changes in frailty and incident cardiovascular disease in three prospective cohorts. Eur Heart J 45:1058\u20131068","journal-title":"Eur Heart J"},{"key":"2928_CR5","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s11886-023-01847-0","volume":"25","author":"D Ko","year":"2023","unstructured":"Ko D, Bostrom JA, Qazi S et al (2023) Frailty and cardiovascular mortality: a narrative review. Curr Cardiol Rep 25:249\u2013259","journal-title":"Curr Cardiol Rep"},{"key":"2928_CR6","doi-asserted-by":"crossref","unstructured":"Chen L, Li X, Lv Y et al (2023) Physical frailty, adherence to ideal cardiovascular health and risk of cardiovascular disease: a prospective cohort study. Age Ageing 52(1)","DOI":"10.1093\/ageing\/afac311"},{"key":"2928_CR7","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1161\/CIR.0000000000001123","volume":"147","author":"CW Tsao","year":"2023","unstructured":"Tsao CW, Aday AW, Almarzooq ZI et al (2023) Heart disease and stroke statistics-2023 update: a report from the American Heart Association. Circulation 147:e93\u2013e621","journal-title":"Circulation"},{"key":"2928_CR8","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.jacc.2013.09.070","volume":"63","author":"J Afilalo","year":"2014","unstructured":"Afilalo J, Alexander KP, Mack MJ et al (2014) Frailty assessment in the cardiovascular care of older adults. J Am Coll Cardiol 63:747\u2013762","journal-title":"J Am Coll Cardiol"},{"key":"2928_CR9","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s12877-024-04836-2","volume":"24","author":"YF Luo","year":"2024","unstructured":"Luo YF, Cheng ZJ, Wang YF et al (2024) Unraveling the relationship between high-sensitivity C-reactive protein and frailty: evidence from longitudinal cohort study and genetic analysis. BMC Geriatr 24:222","journal-title":"BMC Geriatr"},{"issue":"15","key":"2928_CR10","doi-asserted-by":"publisher","first-page":"11902","DOI":"10.3390\/ijms241511902","volume":"24","author":"MV Mill\u00e1n Solano","year":"2023","unstructured":"Mill\u00e1n Solano MV, Salinas Lara C, S\u00e1nchez-Garibay C et al (2023) Effect of systemic inflammation in the CNS: a silent history of neuronal damage. Int J Mol Sci 24(15):11902","journal-title":"Int J Mol Sci"},{"key":"2928_CR11","doi-asserted-by":"publisher","first-page":"579","DOI":"10.3389\/fimmu.2018.00579","volume":"9","author":"WH Boehncke","year":"2018","unstructured":"Boehncke WH (2018) Systemic inflammation and cardiovascular comorbidity in psoriasis patients: causes and consequences. Front Immunol 9:579","journal-title":"Front Immunol"},{"key":"2928_CR12","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.jacc.2021.12.017","volume":"79","author":"L Liberale","year":"2022","unstructured":"Liberale L, Badimon L, Montecucco F et al (2022) Inflammation, aging, and cardiovascular disease: JACC review topic of the week. J Am Coll Cardiol 79:837\u2013847","journal-title":"J Am Coll Cardiol"},{"key":"2928_CR13","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/eurheartj\/ehaa099","volume":"42","author":"PR Lawler","year":"2021","unstructured":"Lawler PR, Bhatt DL, Godoy LC et al (2021) Targeting cardiovascular inflammation: next steps in clinical translation. Eur Heart J 42:113\u2013131","journal-title":"Eur Heart J"},{"key":"2928_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.arr.2016.08.006","volume":"31","author":"P Soysal","year":"2016","unstructured":"Soysal P, Stubbs B, Lucato P et al (2016) Inflammation and frailty in the elderly: a systematic review and meta-analysis. Ageing Res Rev 31:1\u20138","journal-title":"Ageing Res Rev"},{"key":"2928_CR15","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","volume":"370","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M et al (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370:1453\u20131457","journal-title":"Lancet"},{"key":"2928_CR16","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/ije\/dys203","volume":"43","author":"Y Zhao","year":"2014","unstructured":"Zhao Y, Hu Y, Smith JP et al (2014) Cohort profile: the China Health and Retirement Longitudinal Study (CHARLS). Int J Epidemiol 43:61\u201368","journal-title":"Int J Epidemiol"},{"key":"2928_CR17","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1093\/aje\/kwz170","volume":"188","author":"X Chen","year":"2019","unstructured":"Chen X, Crimmins E, Hu PP et al (2019) Venous blood-based biomarkers in the China Health and Retirement Longitudinal Study: rationale, design, and results from the 2015 wave. Am J Epidemiol 188:1871\u20131877","journal-title":"Am J Epidemiol"},{"key":"2928_CR18","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s12933-024-02278-z","volume":"23","author":"C Cui","year":"2024","unstructured":"Cui C, Qi Y, Song J et al (2024) Comparison of triglyceride glucose index and modified triglyceride glucose indices in prediction of cardiovascular diseases in middle aged and older Chinese adults. Cardiovasc Diabetol 23:185","journal-title":"Cardiovasc Diabetol"},{"key":"2928_CR19","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1471-2318-8-24","volume":"8","author":"SD Searle","year":"2008","unstructured":"Searle SD, Mitnitski A, Gahbauer EA et al (2008) A standard procedure for creating a frailty index. BMC Geriatr 8:24","journal-title":"BMC Geriatr"},{"key":"2928_CR20","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/S0140-6736(19)31786-6","volume":"394","author":"EO Hoogendijk","year":"2019","unstructured":"Hoogendijk EO, Afilalo J, Ensrud KE et al (2019) Frailty: implications for clinical practice and public health. Lancet 394:1365\u20131375","journal-title":"Lancet"},{"key":"2928_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.101264","volume":"44","author":"K Gao","year":"2022","unstructured":"Gao K, Cao LF, Ma WZ et al (2022) Association between sarcopenia and cardiovascular disease among middle-aged and older adults: findings from the China Health and Retirement Longitudinal Study. EClinicalMedicine 44:101264","journal-title":"EClinicalMedicine"},{"key":"2928_CR22","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/sim.4067","volume":"30","author":"IR White","year":"2011","unstructured":"White IR, Royston P, Wood AM (2011) Multiple imputation using chained equations: Issues and guidance for practice. Stat Med 30:377\u2013399","journal-title":"Stat Med"},{"key":"2928_CR23","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1503\/cmaj.110977","volume":"184","author":"RH Groenwold","year":"2012","unstructured":"Groenwold RH, White IR, Donders AR et al (2012) Missing covariate data in clinical research: when and when not to use the missing-indicator method for analysis. CMAJ 184:1265\u20131269","journal-title":"CMAJ"},{"key":"2928_CR24","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1001\/jama.2018.21973","volume":"321","author":"H Lee","year":"2019","unstructured":"Lee H, Herbert RD, McAuley JH (2019) Mediation analysis. JAMA 321:697\u2013698","journal-title":"JAMA"},{"key":"2928_CR25","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1093\/eurheartj\/ehab850","volume":"43","author":"W Shrauner","year":"2022","unstructured":"Shrauner W, Lord EM, Nguyen XT et al (2022) Frailty and cardiovascular mortality in more than 3 million US veterans. Eur Heart J 43:818\u2013826","journal-title":"Eur Heart J"},{"key":"2928_CR26","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12916-023-02774-1","volume":"21","author":"X Cao","year":"2023","unstructured":"Cao X, Yang Z, Li X et al (2023) Association of frailty with the incidence risk of cardiovascular disease and type 2 diabetes mellitus in long-term cancer survivors: a prospective cohort study. BMC Med 21:74","journal-title":"BMC Med"},{"key":"2928_CR27","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.ijcard.2017.01.153","volume":"236","author":"QE Denfeld","year":"2017","unstructured":"Denfeld QE, Winters-Stone K, Mudd JO et al (2017) The prevalence of frailty in heart failure: a systematic review and meta-analysis. Int J Cardiol 236:283\u2013289","journal-title":"Int J Cardiol"},{"key":"2928_CR28","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.jacc.2017.06.024","volume":"70","author":"J Afilalo","year":"2017","unstructured":"Afilalo J, Lauck S, Kim DH et al (2017) Frailty in older adults undergoing aortic valve replacement: the FRAILTY-AVR study. J Am Coll Cardiol 70:689\u2013700","journal-title":"J Am Coll Cardiol"},{"key":"2928_CR29","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1016\/j.jcin.2017.07.042","volume":"10","author":"C Metze","year":"2017","unstructured":"Metze C, Matzik AS, Scherner M et al (2017) Impact of frailty on outcomes in patients undergoing percutaneous mitral valve repair. JACC Cardiovasc Interv 10:1920\u20131929","journal-title":"JACC Cardiovasc Interv"},{"key":"2928_CR30","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.jacc.2013.05.016","volume":"62","author":"O Yousuf","year":"2013","unstructured":"Yousuf O, Mohanty BD, Martin SS et al (2013) High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link? J Am Coll Cardiol 62:397\u2013408","journal-title":"J Am Coll Cardiol"},{"key":"2928_CR31","doi-asserted-by":"publisher","first-page":"3168","DOI":"10.1161\/CIRCULATIONAHA.108.783068","volume":"117","author":"P Libby","year":"2008","unstructured":"Libby P, Nahrendorf M, Pittet MJ et al (2008) Diversity of denizens of the atherosclerotic plaque: not all monocytes are created equal. Circulation 117:3168\u20133170","journal-title":"Circulation"},{"key":"2928_CR32","doi-asserted-by":"publisher","first-page":"1150171","DOI":"10.3389\/fendo.2023.1150171","volume":"14","author":"M Obradovic","year":"2023","unstructured":"Obradovic M, Sudar-Milovanovic E, Gluvic Z et al (2023) The Na(+)\/K(+)-ATPase: a potential therapeutic target in cardiometabolic diseases. Front Endocrinol (Lausanne) 14:1150171","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2928_CR33","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1056\/NEJM199704033361401","volume":"336","author":"PM Ridker","year":"1997","unstructured":"Ridker PM, Cushman M, Stampfer MJ et al (1997) Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336:973\u2013979","journal-title":"N Engl J Med"},{"key":"2928_CR34","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.jacc.2021.07.016","volume":"78","author":"W Zhang","year":"2021","unstructured":"Zhang W, Speiser JL, Ye F et al (2021) High-sensitivity C-reactive protein modifies the cardiovascular risk of lipoprotein(a): multi-ethnic study of atherosclerosis. J Am Coll Cardiol 78:1083\u20131094","journal-title":"J Am Coll Cardiol"},{"key":"2928_CR35","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.jacc.2023.05.035","volume":"82","author":"PM Burger","year":"2023","unstructured":"Burger PM, Koudstaal S, Mosterd A et al (2023) C-reactive protein and risk of incident heart failure in patients with cardiovascular disease. J Am Coll Cardiol 82:414\u2013426","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"2928_CR36","doi-asserted-by":"publisher","first-page":"9129","DOI":"10.3390\/ijms24119129","volume":"24","author":"A Kuppa","year":"2023","unstructured":"Kuppa A, Tripathi H, Al-Darraji A et al (2023) C-reactive protein levels and risk of cardiovascular diseases: a two-sample bidirectional Mendelian randomization study. Int J Mol Sci 24(11):9129","journal-title":"Int J Mol Sci"},{"key":"2928_CR37","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s11357-012-9396-8","volume":"35","author":"D Baylis","year":"2013","unstructured":"Baylis D, Bartlett DB, Syddall HE et al (2013) Immune-endocrine biomarkers as predictors of frailty and mortality: a 10-year longitudinal study in community-dwelling older people. Age (Dordr) 35:963\u2013971","journal-title":"Age (Dordr)"},{"key":"2928_CR38","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/j.1365-2265.2005.02355.x","volume":"63","author":"MT Puts","year":"2005","unstructured":"Puts MT, Visser M, Twisk JW et al (2005) Endocrine and inflammatory markers as predictors of frailty. Clin Endocrinol (Oxf) 63:403\u2013411","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2928_CR39","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.amjmed.2009.04.016","volume":"122","author":"AP Reiner","year":"2009","unstructured":"Reiner AP, Aragaki AK, Gray SL et al (2009) Inflammation and thrombosis biomarkers and incident frailty in postmenopausal women. Am J Med 122:947\u2013954","journal-title":"Am J Med"},{"key":"2928_CR40","doi-asserted-by":"publisher","first-page":"1178829","DOI":"10.3389\/fnut.2023.1178829","volume":"10","author":"A Mirzababaei","year":"2023","unstructured":"Mirzababaei A, Abaj F, Khosravinia D et al (2023) The mediatory effect of inflammatory markers on the association between a body shape index and body roundness index with cardiometabolic risk factor in overweight and obese women: a cross-sectional study. Front Nutr 10:1178829","journal-title":"Front Nutr"},{"key":"2928_CR41","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.cell.2014.10.039","volume":"159","author":"BK Kennedy","year":"2014","unstructured":"Kennedy BK, Berger SL, Brunet A et al (2014) Geroscience: linking aging to chronic disease. Cell 159:709\u2013713","journal-title":"Cell"}],"container-title":["Aging Clinical and Experimental Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40520-025-02928-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40520-025-02928-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40520-025-02928-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T13:51:01Z","timestamp":1740750661000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40520-025-02928-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,28]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2928"],"URL":"https:\/\/doi.org\/10.1007\/s40520-025-02928-6","relation":{},"ISSN":["1720-8319"],"issn-type":[{"value":"1720-8319","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,28]]},"assertion":[{"value":"7 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The CHARLS study received ethical approval from the Peking University institutional review board (IRB00001052-11015). The conduction and reporting of this study were in accordance with the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) reporting guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"CHARLS received ethical approval from the Peking University institutional review board (IRB00001052-11015).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of human and animal rights"}},{"value":"Written informed consent was obtained from each participant.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"58"}}